Edition:
United States

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

21.41USD
12:50pm EDT
Change (% chg)

$0.41 (+1.95%)
Prev Close
$21.00
Open
$21.00
Day's High
$21.58
Day's Low
$20.75
Volume
171,777
Avg. Vol
727,452
52-wk High
$27.32
52-wk Low
$8.42

Select another date:

Mon, May 21 2018

BRIEF-Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. FDA

* IMMUNOMEDICS SUBMITS BIOLOGICS LICENSE APPLICATION FOR SACITUZUMAB GOVITECAN TO THE U.S. FOOD AND DRUG ADMINISTRATION

BRIEF-Immunomedics Announces Promising Data Of Sacituzumab Govitecan In Estrogen Receptor-Positive Metastatic Breast Cancer

* IMMUNOMEDICS ANNOUNCES PROMISING DATA OF SACITUZUMAB GOVITECAN IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST CANCER Source text for Eikon: Further company coverage:

BRIEF-Immunomedics Reports Q3 Loss Per Share $0.21

* IMMUNOMEDICS ANNOUNCES THIRD QUARTER FISCAL 2018 RESULTS AND PROVIDES CORPORATE UPDATE

Select another date: